Clinical trial links oncolytic immunoactivation to survival in glioblastoma.

Ling AL, Solomon IH, Landivar AM, Nakashima H, Woods JK, Santos A, Masud N, Fell G, Mo X, Yilmaz AS, Grant J, Zhang A, Bernstock JD, Torio E, Ito H, Liu J, Shono N, Nowicki MO, Triggs D, Halloran P, Piranlioglu R, Soni H, Stopa B, Bi WL, Peruzzi P, Chen E, Malinowski SW, Prabhu MC, Zeng Y, Carlisle A, Rodig SJ, Wen PY, Lee EQ, Nayak L, Chukwueke U, Gonzalez Castro LN, Dumont SD, Batchelor T, Kittelberger K, Tikhonova E, Miheecheva N, Tabakov D, Shin N, Gorbacheva A, Shumskiy A, Frenkel F, Aguilar-Cordova E, Aguilar LK, Krisky D, Wechuck J, Manzanera A, Matheny C, Tak PP, Barone F, Kovarsky D, Tirosh I, Suvà ML, Wucherpfennig KW, Ligon K, Reardon DA, Chiocca EA

Open source

DOI
10.1038/s41586-023-06623-2
Published
2023 Nov
Container
Nature
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41586-023-06623-2,
  title = {Clinical trial links oncolytic immunoactivation to survival in glioblastoma.},
  author = {Ling AL and Solomon IH and Landivar AM and Nakashima H and Woods JK and Santos A and Masud N and Fell G and Mo X and Yilmaz AS and Grant J and Zhang A and Bernstock JD and Torio E and Ito H and Liu J and Shono N and Nowicki MO and Triggs D and Halloran P and Piranlioglu R and Soni H and Stopa B and Bi WL and Peruzzi P and Chen E and Malinowski SW and Prabhu MC and Zeng Y and Carlisle A and Rodig SJ and Wen PY and Lee EQ and Nayak L and Chukwueke U and Gonzalez Castro LN and Dumont SD and Batchelor T and Kittelberger K and Tikhonova E and Miheecheva N and Tabakov D and Shin N and Gorbacheva A and Shumskiy A and Frenkel F and Aguilar-Cordova E and Aguilar LK and Krisky D and Wechuck J and Manzanera A and Matheny C and Tak PP and Barone F and Kovarsky D and Tirosh I and Suvà ML and Wucherpfennig KW and Ligon K and Reardon DA and Chiocca EA},
  year = {2023},
  journal = {Nature},
  doi = {10.1038/s41586-023-06623-2},
  url = {https://doi.org/10.1038/s41586-023-06623-2}
}

RIS

TY  - JOUR
TI  - Clinical trial links oncolytic immunoactivation to survival in glioblastoma.
AU  - Ling AL
AU  - Solomon IH
AU  - Landivar AM
AU  - Nakashima H
AU  - Woods JK
AU  - Santos A
AU  - Masud N
AU  - Fell G
AU  - Mo X
AU  - Yilmaz AS
AU  - Grant J
AU  - Zhang A
AU  - Bernstock JD
AU  - Torio E
AU  - Ito H
AU  - Liu J
AU  - Shono N
AU  - Nowicki MO
AU  - Triggs D
AU  - Halloran P
AU  - Piranlioglu R
AU  - Soni H
AU  - Stopa B
AU  - Bi WL
AU  - Peruzzi P
AU  - Chen E
AU  - Malinowski SW
AU  - Prabhu MC
AU  - Zeng Y
AU  - Carlisle A
AU  - Rodig SJ
AU  - Wen PY
AU  - Lee EQ
AU  - Nayak L
AU  - Chukwueke U
AU  - Gonzalez Castro LN
AU  - Dumont SD
AU  - Batchelor T
AU  - Kittelberger K
AU  - Tikhonova E
AU  - Miheecheva N
AU  - Tabakov D
AU  - Shin N
AU  - Gorbacheva A
AU  - Shumskiy A
AU  - Frenkel F
AU  - Aguilar-Cordova E
AU  - Aguilar LK
AU  - Krisky D
AU  - Wechuck J
AU  - Manzanera A
AU  - Matheny C
AU  - Tak PP
AU  - Barone F
AU  - Kovarsky D
AU  - Tirosh I
AU  - Suvà ML
AU  - Wucherpfennig KW
AU  - Ligon K
AU  - Reardon DA
AU  - Chiocca EA
PY  - 2023
JO  - Nature
DO  - 10.1038/s41586-023-06623-2
UR  - https://doi.org/10.1038/s41586-023-06623-2
ER  -

APA

AL, L., IH, S., AM, L., H, N., JK, W., A, S., N, M., G, F., X, M., AS, Y., J, G., A, Z., JD, B., E, T., H, I., J, L., N, S., MO, N., D, T., P, H., R, P., H, S., B, S., WL, B., P, P., E, C., SW, M., MC, P., Y, Z., A, C., SJ, R., PY, W., EQ, L., L, N., U, C., LN, G. C., SD, D., T, B., K, K., E, T., N, M., D, T., N, S., A, G., A, S., F, F., E, A., LK, A., D, K., J, W., A, M., C, M., PP, T., F, B., D, K., I, T., ML, S., KW, W., K, L., DA, R., & EA, C. (2023). Clinical trial links oncolytic immunoactivation to survival in glioblastoma.. Nature. https://doi.org/10.1038/s41586-023-06623-2

Source records